Biotech News - Celgene Corporation NASDAQ:CELG & Gilead Sciences, Inc. Nasdaq:GILD

Celgene Corporation (Public, NASDAQ:CELG)

Gilead Sciences Completes Acquisition of Raylo Chemicals Inc. and
Celgene Announces Pricing of Common Stock Offering

Biotechnology industry news Gilead Sciences, Inc. (Nasdaq:GILD)
recently announced that the company has completed its acquisition of
Raylo Chemicals Inc., a subsidiary of Germany-based specialty
chemicals company Degussa AG, for approximately 107 million euros.
Gilead intends to utilize this Edmonton, Alberta-based site for
process research and scale-up of clinical development candidates,
for manufacturing of active pharmaceutical ingredients (API) for
both investigational and commercial products and for chemical
development activities to improve existing commercial manufacturing
processes. PDL BioPharma Inc. (Nasdaq:PDLI) said Thursday it posted
a narrower third-quarter loss as revenue jumped 44 percent in large
part on gains from a severed collaboration with Roche. The company
lost $6.7 million, or 6 cents per share, compared with a loss of
$45.2 million, or 43 cents per share, a year ago. Analysts polled by
Thomson Financial expected a loss of 1-cent per share.

Celgene Corporation (Nasdaq: CELG), announced the pricing of its
public offering of 20,000,000 shares of its common stock at a public
offering price of $51.60 per share. The gross proceeds of the
offering will be $1.032 billion. This offering of the shares of
Celgene common stock may be made only by means of a prospectus.
Celgene Corporation, headquartered in Summit, New Jersey, is an
integrated global biopharmaceutical company. NutraCea, (OTC BB:
NTRZ) the world leader in stabilized rice bran technology, is
pleased to announce that its Chief Executive Officer, Mr. Brad
Edson, is scheduled to present at the Rodman & Renshaw 8th Annual
Healthcare Conference on November 6, 2006 at 9:10 a.m. EST. The
three-day conference is being held at the New York Palace in New
York City and will include presentations by over 300 companies, as
well as experts from the medical, scientific and investment
communities.

http://tech.groups.yahoo.com/group/biotech-news/
http://www.arizonabiotech.com/
http://www.azhttp.com/

http://www.arizonabiotech.com/
http://groups.yahoo.com/group/biotech-news/
http://www.arizonaentrepreneurs.com/
http://www.azhttp.com/

Yahoo! Groups Links

<*> To visit your group on the web, go to:
http://groups.yahoo.com/group/biotech-news/

<*> Your email settings:
Individual Email | Traditional

<*> To change settings online go to:
http://groups.yahoo.com/group/biotech-news/join
(Yahoo! ID required)

<*> To change settings via email:
mailto:biotech-news-digest@yahoogroups.com
mailto:biotech-news-fullfeatured@yahoogroups.com

<*> To unsubscribe from this group, send an email to:
biotech-news-unsubscribe@yahoogroups.com

<*> Your use of Yahoo! Groups is subject to:
http://docs.yahoo.com/info/terms/